Invention Application
- Patent Title: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
-
Application No.: US16098245Application Date: 2017-05-04
-
Publication No.: US20190144417A1Publication Date: 2019-05-16
- Inventor: David K. WILLIAMS , Weifanq SHAN , Liping ZHANG , Emily Charlotte CHERNEY , James Aaron BALOG
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- International Application: PCT/US17/30997 WO 20170504
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61P35/00 ; C07D215/18 ; A61K31/4709 ; A61K31/47 ; A61K31/496 ; C07D401/06 ; A61K31/444
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Public/Granted literature
- US11066383B2 Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Public/Granted day:2021-07-20
Information query
